ICON has agreed a multi-year collaboration with Anthropic, aiming to introduce Claude’s AI capabilities into the clinical trial process.
The positive results for ADC ris-rez come as GSK looks to lean on its oncology pipeline and portfolio for future growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results